4//SEC Filing
Landau Jeffrey B 4
Accession 0001610717-23-000421
CIK 0001501989other
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 4:12 PM ET
Size
6.1 KB
Accession
0001610717-23-000421
Insider Transaction Report
Form 4
Landau Jeffrey B
Chief Business Officer
Transactions
- Sale
Common Stock
2023-12-20$1.38/sh−4,077$5,628→ 86,622 total
Holdings
- 4,500(indirect: By IRA)
Common Stock
- 3,180(indirect: By IRA)
Common Stock
Footnotes (2)
- [F1]The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of PSUs previously reported on December 19, 2023.
- [F2]Includes 52,205 restricted stock units.
Documents
Issuer
CytomX Therapeutics, Inc.
CIK 0001501989
Entity typeother
Related Parties
1- filerCIK 0001918615
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 4:12 PM ET
- Size
- 6.1 KB